Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Karisma-1: Tamoxifen for mammographic density reduction
NCT04079517Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- Mar 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by Karolinska Institutet. Started Mar 2015; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04079517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079517.